An Approach to Optic Neuropathies
DOI:
https://doi.org/10.58931/cect.2023.2120Abstract
Optic neuropathies are varied in their clinical presentations, etiologies, recommended diagnostic investigations, and treatments. This article aims to provide a practical framework to guide the evaluation of a patient suspected of an optic neuropathy.
References
Prasad S, Volpe NJ, Balcer LJ. Approach to optic neuropathies: clinical update. Neurologist. 2010 Jan;16(1):23-34. DOI: https://doi.org/10.1097/NRL.0b013e3181be6fad
Sadun AA, Patel VR. Differentiating Optic Nerve from Macular disease. Yanoff and Duker: Ophthalmology 3rd Edition. 2008 Mosby Inc. DOI: https://doi.org/10.1016/B978-0-323-04332-8.00158-X
Wall M. Update on Idiopathic Intracranial Hypertension. Neurol Clin. 2017 Feb;35(1):45-57. DOI: https://doi.org/10.1016/j.ncl.2016.08.004
Murphy LS, Lacy AJ, Smith AT, Shah KS. Cryptococcal meningitis in an immunocompetent patient. Am J Emerg Med. 2020 Nov;38(11):2492.e1-2492.e3. DOI: https://doi.org/10.1016/j.ajem.2020.05.115
Hickman SJ. Optic Perineuritis. Curr Neurol Neurosci Rep. 2016 Feb;16(2):16. doi:10.1007/s11910-015-0617-2. DOI: https://doi.org/10.1007/s11910-015-0617-2
Hayreh SS. Diabetic papillopathy and nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2002 Nov-Dec;47(6):600-2; author reply 602. DOI: https://doi.org/10.1016/S0039-6257(02)00358-2
Teja S, Patel VR. Ischemic Optic Neuropathies: Diagnosis and Management. Int. Ophthalmol Clin. 2019 Summer; 59(3):39-57. DOI: https://doi.org/10.1097/IIO.0000000000000282
Abel A, McClelland C, Lee MS. Critical review: Typical and atypical optic neuritis. Surv Ophthalmol. 2019 Nov-Dec;64(6):770-779. DOI: https://doi.org/10.1016/j.survophthal.2019.06.001
Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, Dickersin K; Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002 Sep;134(3):317-28. DOI: https://doi.org/10.1016/S0002-9394(02)01639-2
Passman RS, Bennett CL, Purpura JM, Kapur R, Johnson LN, Raisch DW, West DP, Edwards BJ, Belknap SM, Liebling DB, Fisher MJ, Samaras AT, Jones LG, Tulas KM, McKoy JM. Amiodarone-associated optic neuropathy: a critical review. Am J Med. 2012 May;125(5):447-53. DOI: https://doi.org/10.1016/j.amjmed.2011.09.020
Chen JJ, Bhatti MT. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Curr Opin Neurol. 2020 Feb;33(1):47-54. DOI: https://doi.org/10.1097/WCO.0000000000000766
Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Arch Ophthalmol. 1991;109:1673–8. DOI: https://doi.org/10.1001/archopht.1991.01080120057025
Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol. 2001 Nov;132(5):743-50. DOI: https://doi.org/10.1016/S0002-9394(01)01199-0
Grzybowski A, Zülsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015 Aug;93(5):402-10. DOI: https://doi.org/10.1111/aos.12515
Marignier R, Hacohen Y, Cobo-Calvo A, Pröbstel AK, Aktas O, Alexopoulos H, Amato MP, Asgari N, Banwell B, Bennett J, Brilot F, Capobianco M, Chitnis T, Ciccarelli O, Deiva K, De Sèze J, Fujihara K, Jacob A, Kim HJ, Kleiter I, Lassmann H, Leite MI, Linington C, Meinl E, Palace J, Paul F, Petzold A, Pittock S, Reindl M, Sato DK, Selmaj K, Siva A, Stankoff B, Tintore M, Traboulsee A, Waters P, Waubant E, Weinshenker B, Derfuss T, Vukusic S, Hemmer B. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021 Sep;20(9):762-772. DOI: https://doi.org/10.1016/S1474-4422(21)00218-0
Weinshenker BG, Wingerchuk DM. Neuromyelitis Spectrum Disorders. Mayo Clin Proc. 2017 Apr;92(4):663-679. DOI: https://doi.org/10.1016/j.mayocp.2016.12.014
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.